In Vitro Protein Expression Systems

In Vitro Protein Expression Systems

Global In Vitro Protein Expression Systems Market to Reach $276.9 Million by 2030
The global market for In Vitro Protein Expression Systems estimated at US$203 Million in the year 2023, is expected to reach US$276.9 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. E-Coli In Vitro Protein Expression Systems, one of the segments analyzed in the report, is expected to record a 5% CAGR and reach US$147.7 Million by the end of the analysis period. Growth in the Mammalian In Vitro Protein Expression Systems segment is estimated at 4.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $60 Million, While China is Forecast to Grow at 4.2% CAGR
The In Vitro Protein Expression Systems market in the U.S. is estimated at US$60 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 3.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 12 Featured) -
  • Bioneer Corporation
  • biotechrabbit GmbH
  • CellFree Sciences Co., Ltd.
  • Cube Biotech GmbH
  • GeneCopoeia, Inc.
  • Jena Bioscience GmbH
  • New England Biolabs, Inc.
  • Promega Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
In Vitro Protein Expression Systems - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World In Vitro Protein Expression Systems Market Analysis of Annual Sales in US$ for Years 2014 through 2030
TABLE 5: World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for E-Coli by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
JAPAN
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 41: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
CHINA
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 44: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 47: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
EUROPE
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
FRANCE
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 59: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
GERMANY
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 90: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 91: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 95: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of World Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 98: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings